Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

Male Carcinoma, Hepatocellular Science Q Liver Neoplasms R 610 Middle Aged Prognosis 3. Good health 03 medical and health sciences 0302 clinical medicine Medicine Humans Female Chemoembolization, Therapeutic Research Article Aged
DOI: 10.1371/journal.pone.0180408 Publication Date: 2017-07-03T17:37:11Z
ABSTRACT
Various noninvasive liver reserve markers were proposed to indicate the severity of damage. However, role and feasibility these predict prognosis patients with hepatocellular carcinoma (HCC) are unknown. We aimed identify prognostic 8 currently used hepatic in HCC undergoing transarterial chemoembolization (TACE).Between 2002 2013, a total 881 TACE prospectively identified retrospectively analyzed. The baseline characteristics, tumor status collected. Homogeneity corrected Akaike information criteria (AICc) compared between markers. Cox proportional hazards model was independent predictors survival.Significant differences survival distribution found for albumin-bilirubin (ALBI) grade, Child-Turcotte-Pugh (CTP) class, Lok index, fibrosis index based on 4 factors (FIB-4), Göteborg University cirrhosis (GUCI), discriminant (CDI) end-stage disease (MELD) score (all p values <0.05). Among markers, ALBI grade showed highest homogeneity lowest AICc value, indicating better performance. multivariate analysis confirmed that 2, ascites, serum alkaline phosphatase α-fetoprotein level, diameter, vascular invasion performance significant predictors. well correlated CTP MLED scores.Our data suggest among may serve as an objective feasible surrogate TACE.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (33)